Agios Pharmaceuticals Inc at RBC Global Healthcare Conference (Virtual) Transcript
All right. Thank you so much for joining our next session here. My name is Kennen MacKay. I'm one of the Senior Biotechnology Analysts here at RBC, and it's my great pleasure to have with us on this next session, Agios. And from Agios, we have Dr. Jackie Fouse, Agios' Chief Executive Officer. Jackie, thanks so much for joining.
Happy to be here, being late is my fault you can tell them that. So...
I'll shoulder the blame of the technical difficulties. Thank you, again, for joining. Thank you again for doing a video. Before we dive in with some fireside chat questions Agios is really at sort of a pivotal point in terms of the company's history now with really some potentially major rare disease programs very close on the horizon. Maybe you can
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |